Beam Therapeutics Inc. (NASDAQ:BEAM), a biotechnology company at the forefront of precision genetic medicines with a market capitalization of $1.87 billion, is navigating a critical juncture in its ...

Gene therapy involves the introduction of new genes into cells, to restore or add gene expression, for the purpose of treating disease. Most commonly a mutated gene is replaced with DNA encoding a ...

Ongoing launch of CASGEVY® continues to gain momentum--2025 is poised to be a catalyst-rich year with key updates across several ...

Short-chain fatty acids influence gene regulation and chromatin accessibility, highlighting their role in colorectal cancer ...

The Gates Foundation will invest up to $50 million to support Tessera's SCD gene editing treatment, the company said.

Gene-editing kicked off 2024 with a bang in the medical sector but closed the year with a whimper. It started with the FDA ...

Treatments for rare diseases are hard to create and expensive to deliver, but there is new hope for editing the software of ...

Vaccines and aborted fetal tissue are linked in some cases. That's because certain vaccines, such as a type of rabies vaccine, are made by cultivating the virus in fetal cells. The Janssen COVID-19 ...

We researched over 35 mental health platforms and narrowed down 6 options for affordable online therapy. Follow our testers as they sign up and try the platforms to see if one could be a fit for you.

*Refers to the latest 2 years of omaha.com stories. Cancel anytime. A preview of Nebraska Medicine's Innovation Design Unit in December 2024 After more than four decades of infusing himself with ...

Growth Drivers of The Gene Therapy Industry As per IMARC, the US gene therapy market size has been pegged at US$1,312.2 million in 2024. The market should reach US$3,697.8 million by 2033.

The third annual Fetal Therapy Workshop was held in Pune from December 21 to 23, 2024, attracting experts across India. Key procedures like radiofrequency ablation and fetoscopic laser therapy ...